@misc{indiciae904b0440daf0,
  title = {HER2 mutation-derived neoantigens in NSCLC as actionable targets for TCR therapy},
  author = {Montoya, A. and Nie, H. and Jiang, P. and Slone, J. and Shulga, Y. and Patel, A. and Menon, P. and Polic, I. and Bontekoe, E. and Hong, L. and Zhang, M. and Assita, E. R. and Forward, S. and Xing, C. and Jiang, B. and Deniger, D. C. and Lizee, G. A. and Varadarajan, N. and Le, X. and Zhang, J. and Kavraki, L. and Kwok, S. J. and Heymach, J. and Reuben, A.},
  year = {2026},
  doi = {10.64898/2026.07.30.741830},
  url = {https://www.biorxiv.org/content/10.64898/2026.07.30.741830v1},
  note = {Source identifier: 10.64898/2026.07.30.741830}
}